Corticosteroids in critically ill patients with community-acquired pneumonia: A systematic review and Bayesian meta-analysis.
10.47102/annals-acadmedsg.2024159
- Author:
Wei Yu CHUA
1
;
Natalie CHEW
1
;
Shruthi C IYER
1
;
Rachel GOH
1
;
Wei Ren Ryanna KOH
2
;
Hong Lien VU
2
;
Qai Ven YAP
3
;
Miny SAMUEL
4
;
John SOONG
2
;
Matthew Edward COVE
2
Author Information
1. Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
2. Department of Medicine, National University Hospital, Singapore.
3. Department of Biostatistics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
4. Research Support Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
- Publication Type:Systematic Review
- Keywords:
Bayesian meta-analysis;
ICU;
community-acquired pneumonia;
corticosteroids;
critically ill;
mortality
- MeSH:
Humans;
Adrenal Cortex Hormones/therapeutic use*;
Bayes Theorem;
Community-Acquired Infections/mortality*;
Critical Illness;
Hospital Mortality;
Intensive Care Units;
Pneumonia, Bacterial/mortality*;
Randomized Controlled Trials as Topic;
Respiration, Artificial
- From:Annals of the Academy of Medicine, Singapore
2024;53(11):683-693
- CountrySingapore
- Language:English
-
Abstract:
INTRODUCTION:This systematic review and meta-analysis aimed to evaluate the effectiveness and safety of adjunct systemic corticosteroid therapy in patients admitted to the intensive care unit (ICU) with bacterial community-acquired pneumonia (CAP).
METHOD:We searched MEDLINE, Embase and the Cochrane Library to identify randomised controlled trials (RCTs) published from the databases' inception to February 2024. All RCTs evaluating the effect of systemic corticosteroids on mortality, compared to standard of care among adult bacterial CAP patients admitted to ICU were included. Bayesian meta-analysis was conducted in line with the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Independent authors reviewed each study for eligibility, extracted data and assessed risk of bias in duplicate, with discrepancies referred to senior reviewers.
RESULTS:A total of 6 RCTs comprising 1585 patients were included for analysis. In ICU patients with severe CAP who were treated with corticosteroids, there was no significant reduction in hospital mortality (risk ratio [RR] 0.70, 95% confidence interval [CI] 0.39-1.14, certainty of evidence: ⊕⊕⊝⊝ low) or all-cause mortality (RR 0.68, 95% CI 0.34-1.22, ⊕⊕⊝⊝ low) compared with placebo. The use of corticosteroids showed a significant reduction in mechanical ventilation post-intervention (RR 0.58, 95% CI 0.37-0.86, ⊕⊕⊕⊕ high) compared with placebo. In a subgroup analysis of patients treated with hydrocortisone, hospital mortality was significantly reduced (RR 0.45, 95% CI 0.20-0.88, ⊕⊕⊝⊝ low) compared with placebo. There was no significant increase in gastrointestinal bleeding, secondary infections or hyperglycaemia in patients treated with corticosteroids.
CONCLUSION:Corticosteroids significantly reduced mechanical ventilation requirements, and hydrocor-tisone significantly reduced hospital mortality. Further work is required to determine whether other corticosteroids reduce mortality among ICU patients with CAP.
